Announcing the newest addition to our portfolio of synthetic viral controls: RNA control for H5N1 Influenza A! NGS-verified, and covering 99.9% of hemagglutinin (HA) & neuraminidase (NA) genome regions.
“As agricultural and infectious disease researchers around the world continue to monitor the spread of H5N1, we continue our unwavering commitment to responding rapidly to threats to public health by providing innovative and critical tools to safeguard our global community and enable monitoring and surveillance as well as vaccine and assay development,” said Emily Leproust, CEO and co-founder of Twist Bioscience. “Our synthetic controls, including the H5N1 Influenza A control, enable broader research access without the need for live viruses. This allows critical work to be conducted in BSL-1 labs, accelerating research and development efforts. Importantly, we maintain biosecurity as a core tenet across all our products and processes. By empowering global research with safe, synthetic tools, we're advancing science while upholding the highest safety standards.”
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A: https://lnkd.in/gEsKJrVN
CEO at Prozomix Limited
1dAt 11 years old I was inspired to become a biologist by such a piece at school, I will be recommending my local school makes a special session for Emily’s talk, wow!